IT has no strength. It completely moves with the market. If the market corrects, it will break down. We now wait until they actually present data, announce a partner or update discussions with the FDA. This is potentially a $40+ stock, but we need to reason to shoot up. Great company, but not for the faint of heart in the short term.
When you get run over this badly, most genius investors would actually do something. Now Ackman is no genius and is definitely a narcissist, so do something and spin off your real estate into the hottest market in sometime or put the Company up for sale. JCP isn't a candy store to the rest of us.
Time for an Icahn like investor to prompt a short squeeze. Buyout specialists have been targeting heavily shorted stocks to screw them and create the squeeze for value. Lets hope this is now on someone's list.
This is a coordinated short attack. Pure manipulation that the SEC is supposed to be dealing with. Earnings will be strong and a short squeeze should correct, but geez, could this illegal action be any clearer?